These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 10373064

  • 21. Topics in bone marrow biopsy pathology: role of marrow topography in myelodysplastic syndromes and evaluation of post-treatment and post-bone marrow transplant biopsies.
    Reddy VV.
    Ann Diagn Pathol; 2001 Apr; 5(2):110-20. PubMed ID: 11294998
    [Abstract] [Full Text] [Related]

  • 22. Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation.
    Choi SW, Boxer LA, Pulsipher MA, Roulston D, Hutchinson RJ, Yanik GA, Cooke KR, Ferrara JL, Levine JE.
    Bone Marrow Transplant; 2005 Mar; 35(5):473-7. PubMed ID: 15640815
    [Abstract] [Full Text] [Related]

  • 23. Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?
    Hake CR, Graubert TA, Fenske TS.
    Bone Marrow Transplant; 2007 Jan; 39(2):59-70. PubMed ID: 17143301
    [Abstract] [Full Text] [Related]

  • 24. Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy.
    Laurenti L, Tarnani M, Chiusolo P, La Torre G, Garzia M, Zollino M, Zini G, Balducci M, Leone G, Sica S.
    Clin Transplant; 2008 Jan; 22(2):191-9. PubMed ID: 18339139
    [Abstract] [Full Text] [Related]

  • 25. AIDS-related bone marrow lesions--myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling.
    Thiele J, Zirbes TK, Bertsch HP, Titius BR, Lorenzen J, Fischer R.
    Anal Cell Pathol; 1996 Aug; 11(3):141-57. PubMed ID: 8888951
    [Abstract] [Full Text] [Related]

  • 26. Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma.
    Bhatia R, Van Heijzen K, Palmer A, Komiya A, Slovak ML, Chang KL, Fung H, Krishnan A, Molina A, Nademanee A, O'Donnell M, Popplewell L, Rodriguez R, Forman SJ, Bhatia S.
    J Clin Oncol; 2005 Sep 20; 23(27):6699-711. PubMed ID: 16170178
    [Abstract] [Full Text] [Related]

  • 27. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N, Bornhäuser M, Ehninger G, Schwerdtfeger R, Biersack H, Sayer HG, Wandt H, Schäfer-Eckardt K, Beyer J, Kiehl M, Zander AR, German Cooperative Transplant Study Group.
    Ann Hematol; 2003 Jun 20; 82(6):336-42. PubMed ID: 12728337
    [Abstract] [Full Text] [Related]

  • 28. Special Education: Aplastic Anemia.
    Teramura M, Mizoguchi H.
    Oncologist; 1996 Jun 20; 1(3):187-189. PubMed ID: 10387986
    [Abstract] [Full Text] [Related]

  • 29. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG, Hellström-Lindberg E, Kanter-Lewensohn L, Lerner R, Palmblad J.
    Leuk Res; 2006 Mar 20; 30(3):247-53. PubMed ID: 16099505
    [Abstract] [Full Text] [Related]

  • 30. Human herpesvirus 6 infection and transient acquired myelodysplasia in children.
    Kagialis-Girard S, Durand B, Mialou V, Pagès MP, Galambrun C, Bertrand Y, Negrier C.
    Pediatr Blood Cancer; 2006 Oct 15; 47(5):543-8. PubMed ID: 16333831
    [Abstract] [Full Text] [Related]

  • 31. Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis.
    Forrest DL, Nevill TJ, Naiman SC, Le A, Brockington DA, Barnett MJ, Lavoie JC, Nantel SH, Song KW, Shepherd JD, Sutherland HJ, Toze CL, Davis JH, Hogge DE.
    Bone Marrow Transplant; 2003 Nov 15; 32(9):915-23. PubMed ID: 14561993
    [Abstract] [Full Text] [Related]

  • 32. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
    Cesaro S, Meloni G, Messina C, Pillon M, Proglia A, Lanino E, Caniggia M, Bagnulo S, Pession A, Locatelli F, Italian Pediatric Group for Bone Marrow Transplantation.
    Bone Marrow Transplant; 2001 Jul 15; 28(2):131-6. PubMed ID: 11509930
    [Abstract] [Full Text] [Related]

  • 33. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
    Konoplev S, Medeiros LJ, Lennon PA, Prajapati S, Kanungo A, Lin P.
    Cancer; 2007 Oct 01; 110(7):1520-6. PubMed ID: 17701956
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS).
    Cantù Rajnoldi A, Fenu S, Kerndrup G, van Wering ER, Niemeyer CM, Baumann I, European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS).
    Ann Hematol; 2005 Jul 01; 84(7):429-33. PubMed ID: 15838669
    [Abstract] [Full Text] [Related]

  • 35. [Diagnosis and therapy strategy in myelodysplastic syndromes].
    Gattermann N, Aul C.
    Praxis (Bern 1994); 1996 Jan 16; 85(3):39-44. PubMed ID: 8578048
    [Abstract] [Full Text] [Related]

  • 36. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
    Cermák J, Belicková M, Krejcová H, Michalová K, Zilovcová S, Zemanová Z, Brezinová J, Sieglová Z.
    Leuk Res; 2005 Apr 16; 29(4):371-9. PubMed ID: 15725470
    [Abstract] [Full Text] [Related]

  • 37. Cytogenetic characteristics of patients with signs and symptoms of myelodysplastic syndromes in the State of Pará, Brazil.
    Pinto GR, Overal DJ, Moraes LS, Van Den Berg AV, Lemos JA, Smith Mde A, Burbano RR.
    Genet Mol Res; 2005 Mar 31; 4(1):18-30. PubMed ID: 15841432
    [Abstract] [Full Text] [Related]

  • 38. Myelodysplastic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma.
    Przepiorka D, Buadi F, McClune B, Franz G, Walsh W, White F.
    Bone Marrow Transplant; 2007 Oct 31; 40(8):759-64. PubMed ID: 17680015
    [Abstract] [Full Text] [Related]

  • 39. High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.
    Forrest DL, Hogge DE, Nevill TJ, Nantel SH, Barnett MJ, Shepherd JD, Sutherland HJ, Toze CL, Smith CA, Lavoie JC, Song KW, Voss NJ, Gascoyne RD, Connors JM.
    J Clin Oncol; 2005 Nov 01; 23(31):7994-8002. PubMed ID: 16204014
    [Abstract] [Full Text] [Related]

  • 40. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.
    Malcovati L, Porta MG, Pascutto C, Invernizzi R, Boni M, Travaglino E, Passamonti F, Arcaini L, Maffioli M, Bernasconi P, Lazzarino M, Cazzola M.
    J Clin Oncol; 2005 Oct 20; 23(30):7594-603. PubMed ID: 16186598
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.